GEMINI SPACE STATION INC-A (GEMI) Fundamental Analysis & Valuation

NASDAQ:GEMI • US36866J1051

Current stock price

4.29 USD
+0.01 (+0.23%)
At close:
4.28 USD
-0.01 (-0.23%)
After Hours:

This GEMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GEMI Profitability Analysis

1.1 Basic Checks

  • GEMI had negative earnings in the past year.
GEMI Yearly Net Income VS EBIT VS OCF VS FCFGEMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of GEMI (-20.06%) is worse than 90.83% of its industry peers.
  • GEMI has a Return On Equity of -71.76%. This is amonst the worse of the industry: GEMI underperforms 88.33% of its industry peers.
Industry RankSector Rank
ROA -20.06%
ROE -71.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GEMI Yearly ROA, ROE, ROICGEMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 100 -100 200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GEMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEMI Yearly Profit, Operating, Gross MarginsGEMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 -100 -200 -300

3

2. GEMI Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, GEMI has about the same amount of shares outstanding.
  • GEMI has a worse debt/assets ratio than last year.
GEMI Yearly Shares OutstandingGEMI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
GEMI Yearly Total Debt VS Total AssetsGEMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 500M 1B 1.5B

2.2 Solvency

  • GEMI has an Altman-Z score of -0.99. This is a bad value and indicates that GEMI is not financially healthy and even has some risk of bankruptcy.
  • GEMI has a worse Altman-Z score (-0.99) than 85.00% of its industry peers.
  • GEMI has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • GEMI has a Debt to Equity ratio of 0.37. This is in the better half of the industry: GEMI outperforms 71.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -0.99
ROIC/WACCN/A
WACCN/A
GEMI Yearly LT Debt VS Equity VS FCFGEMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • GEMI has a Current Ratio of 1.29. This is a normal value and indicates that GEMI is financially healthy and should not expect problems in meeting its short term obligations.
  • GEMI has a Current ratio (1.29) which is in line with its industry peers.
  • A Quick Ratio of 1.29 indicates that GEMI should not have too much problems paying its short term obligations.
  • GEMI has a Quick ratio of 1.29. This is comparable to the rest of the industry: GEMI outperforms 58.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
GEMI Yearly Current Assets VS Current LiabilitesGEMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M 800M 1B

3

3. GEMI Growth Analysis

3.1 Past

  • The earnings per share for GEMI have decreased strongly by -306.36% in the last year.
  • GEMI shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.46%.
EPS 1Y (TTM)-306.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-765.66%
Revenue 1Y (TTM)29.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%106.25%

3.2 Future

  • GEMI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.86% yearly.
  • Based on estimates for the next years, GEMI will show a very strong growth in Revenue. The Revenue will grow by 46.88% on average per year.
EPS Next Y-292%
EPS Next 2Y-45.86%
EPS Next 3Y-7.86%
EPS Next 5YN/A
Revenue Next Year21.99%
Revenue Next 2Y46.44%
Revenue Next 3Y46.88%
Revenue Next 5YN/A

3.3 Evolution

GEMI Yearly Revenue VS EstimatesGEMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 100M 200M 300M 400M
GEMI Yearly EPS VS EstimatesGEMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3 -4 -5

0

4. GEMI Valuation Analysis

4.1 Price/Earnings Ratio

  • GEMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GEMI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEMI Price Earnings VS Forward Price EarningsGEMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEMI Per share dataGEMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • GEMI's earnings are expected to decrease with -7.86% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.86%
EPS Next 3Y-7.86%

0

5. GEMI Dividend Analysis

5.1 Amount

  • No dividends for GEMI!.
Industry RankSector Rank
Dividend Yield 0%

GEMI Fundamentals: All Metrics, Ratios and Statistics

GEMINI SPACE STATION INC-A

NASDAQ:GEMI (4/2/2026, 8:00:01 PM)

After market: 4.28 -0.01 (-0.23%)

4.29

+0.01 (+0.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-19
Earnings (Next)N/A
Inst Owners27.85%
Inst Owner Change3.2%
Ins Owners1.57%
Ins Owner Change0.27%
Market Cap504.72M
Revenue(TTM)162.53M
Net Income(TTM)-468.98M
Analysts72.5
Price Target12.95 (201.86%)
Short Float %13.95%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-36.66%
PT rev (3m)-51.89%
EPS NQ rev (1m)-5.32%
EPS NQ rev (3m)-19.55%
EPS NY rev (1m)10.41%
EPS NY rev (3m)4.12%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-5.47%
Revenue NY rev (1m)0.64%
Revenue NY rev (3m)-1.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.11
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)-9.31
EYN/A
EPS(NY)-2.87
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.38
BVpS5.56
TBVpS4.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.06%
ROE -71.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -0.99
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-306.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-765.66%
EPS Next Y-292%
EPS Next 2Y-45.86%
EPS Next 3Y-7.86%
EPS Next 5YN/A
Revenue 1Y (TTM)29.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%106.25%
Revenue Next Year21.99%
Revenue Next 2Y46.44%
Revenue Next 3Y46.88%
Revenue Next 5YN/A
EBIT growth 1Y2.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-57.5%
EBIT Next 3Y16.67%
EBIT Next 5YN/A
FCF growth 1Y46.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.44%
OCF growth 3YN/A
OCF growth 5YN/A

GEMINI SPACE STATION INC-A / GEMI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GEMI.


What is the valuation status for GEMI stock?

ChartMill assigns a valuation rating of 0 / 10 to GEMINI SPACE STATION INC-A (GEMI). This can be considered as Overvalued.


What is the profitability of GEMI stock?

GEMINI SPACE STATION INC-A (GEMI) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for GEMI stock?

The Earnings per Share (EPS) of GEMINI SPACE STATION INC-A (GEMI) is expected to decline by -292% in the next year.